JESTY GEORGE: Open Payments
NPI 1922633874 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,338 in 181 payments from 24 companies in 2025. Trend: 2023 $2,492 · 2024 $3,908 · 2025 $3,338
Food & beverage: $3,315Honoraria: $23
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $710 |
| PFIZER INC. | 26 | $363 |
| UCB, Inc. | 16 | $345 |
| Neurocrine BioSciences, Inc. | 11 | $269 |
| Novartis Pharmaceuticals Corporation | 19 | $230 |
| EMD Serono, Inc. | 10 | $221 |
| Genentech USA, Inc. | 6 | $127 |
| SK Life Science, Inc. | 4 | $126 |
| Eisai Inc. | 5 | $119 |
| ACADIA Pharmaceuticals Inc | 5 | $114 |
Products named: QULIPTA, NURTEC ODT, INGREZZA, KESIMPTA, Rystiggo, Ocrevus Zunovo, Leqembi, NUPLAZID.
Industry payments across TX — which companies pay providers there.
